Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Multi-national, Multi-centre, Double-blind Placebo-controlled Parallel Group, 26 Week Study to Assess the Maintenance of Clinical Response to Humanised Anti-TNF PEG Conjugate, CDP870 400 mg sc, (Dosed 4-weekly From Weeks 8 to 24), in the Treatment of Patients With Active Crohn's Disease Who Have Responded to Open Induction Therapy (Dosed at Weeks 0, 2 and 4) With CDP870
Brief Summary: A 26 week maintenance study of CDP870 in Crohn's disease


Options:
A: Arm Label: Group I: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo; Ustekinumab (CNTO 1275) 45 or 90 mg | Arm Label: Group II: Ustekinumab 45 mg; Type: EXPERIMENTAL; Interventions: Drug: Ustekinumab (CNTO 1275) 45 mg | Arm Label: Group III: Ustekinumab 90 mg; Type: EXPERIMENTAL; Interventions: Drug: Ustekinumab (CNTO 1275) 90 mg | Intervention Type: DRUG; Name: Placebo; Ustekinumab (CNTO 1275) 45 or 90 mg; Assigned to Arm(s): Group I: Placebo | Intervention Type: DRUG; Name: Ustekinumab (CNTO 1275) 45 mg; Assigned to Arm(s): Group II: Ustekinumab 45 mg | Intervention Type: DRUG; Name: Ustekinumab (CNTO 1275) 90 mg; Assigned to Arm(s): Group III: Ustekinumab 90 mg
B: Intervention Type: DRUG; Name: Certolizumab Pegol (CDP870); Assigned to Arm(s): N/A
C: Arm Label: Placebo (IP); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (IP) | Arm Label: Ustekinumab 1mg/kg (IP); Type: EXPERIMENTAL; Interventions: Drug: Ustekinumab 1mg/kg (IP) | Arm Label: Ustekinumab 3 mg/kg (IP); Type: EXPERIMENTAL; Interventions: Drug: Ustekinumab 3 mg/kg (IP) | Arm Label: Ustekinumab 6 mg/kg (IP); Type: EXPERIMENTAL; Interventions: Drug: Ustekinumab 6 mg/kg (IP) | Arm Label: Placebo IV - Responder - Placebo SC (MP); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo IV - Responder - Placebo SC (MP) | Arm Label: Placebo IV - Nonresponder - Ustekinumab 270/90 mg SC; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo IV - Nonresponder - Ustekinumab 270/90 mg SC (MP) | Arm Label: Ustekinumab IV - Responder - Placebo SC (MP); Type: PLACEBO_COMPARATOR; Interventions: Drug: Ustekinumab IV - Responder - Placebo SC (MP) | Arm Label: Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP); Type: EXPERIMENTAL; Interventions: Drug: Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP) | Arm Label: Ustekinumab IV - Nonresponder - Placebo SC (MP); Type: PLACEBO_COMPARATOR; Interventions: Drug: Ustekinumab IV - Nonresponder - Placebo SC (MP) | Arm Label: Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP); Type: EXPERIMENTAL; Interventions: Drug: Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP) | Intervention Type: DRUG; Name: Placebo (IP); Assigned to Arm(s): Placebo (IP) | Intervention Type: DRUG; Name: Ustekinumab 1mg/kg (IP); Assigned to Arm(s): Ustekinumab 1mg/kg (IP) | Intervention Type: DRUG; Name: Ustekinumab 3 mg/kg (IP); Assigned to Arm(s): Ustekinumab 3 mg/kg (IP) | Intervention Type: DRUG; Name: Ustekinumab 6 mg/kg (IP); Assigned to Arm(s): Ustekinumab 6 mg/kg (IP) | Intervention Type: DRUG; Name: Placebo IV - Responder - Placebo SC (MP); Assigned to Arm(s): Placebo IV - Responder - Placebo SC (MP) | Intervention Type: DRUG; Name: Placebo IV - Nonresponder - Ustekinumab 270/90 mg SC (MP); Assigned to Arm(s): Placebo IV - Nonresponder - Ustekinumab 270/90 mg SC | Intervention Type: DRUG; Name: Ustekinumab IV - Responder - Placebo SC (MP); Assigned to Arm(s): Ustekinumab IV - Responder - Placebo SC (MP) | Intervention Type: DRUG; Name: Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP); Assigned to Arm(s): Ustekinumab IV - Responder - Ustekinumab 90mg SC (MP) | Intervention Type: DRUG; Name: Ustekinumab IV - Nonresponder - Placebo SC (MP); Assigned to Arm(s): Ustekinumab IV - Nonresponder - Placebo SC (MP) | Intervention Type: DRUG; Name: Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP); Assigned to Arm(s): Ustekinumab IV - Nonresponder - Ustekinumab 90mg SC (MP)
D: Arm Label: 001; Type: PLACEBO_COMPARATOR; Interventions: Drug: Group 1: Placebo | Arm Label: 002; Type: EXPERIMENTAL; Interventions: Drug: Group 2 ustekinumab 130 mg | Arm Label: 003; Type: EXPERIMENTAL; Interventions: Drug: Group 3: ustekinumab approximately 6 mg/kg | Intervention Type: DRUG; Name: Group 2 ustekinumab 130 mg; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: Group 3: ustekinumab approximately 6 mg/kg; Assigned to Arm(s): 003 | Intervention Type: DRUG; Name: Group 1: Placebo; Assigned to Arm(s): 001

Answer: B